These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29440069)

  • 1. Therapeutic Opportunities in Eukaryotic Translation.
    Chu J; Pelletier J
    Cold Spring Harb Perspect Biol; 2018 Jun; 10(6):. PubMed ID: 29440069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the translation machinery in cancer.
    Bhat M; Robichaud N; Hulea L; Sonenberg N; Pelletier J; Topisirovic I
    Nat Rev Drug Discov; 2015 Apr; 14(4):261-78. PubMed ID: 25743081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets.
    Sehrawat U
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of translation initiation as cancer therapeutics.
    Lindqvist L; Pelletier J
    Future Med Chem; 2009 Dec; 1(9):1709-22. PubMed ID: 21425987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting translation regulators improves cancer therapy.
    Jiang SL; Mo JL; Peng J; Lei L; Yin JY; Zhou HH; Liu ZQ; Hong WX
    Genomics; 2021 Jan; 113(1 Pt 2):1247-1256. PubMed ID: 33189778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
    Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
    Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
    Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
    Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents.
    Fan A; Sharp PP
    J Med Chem; 2021 Mar; 64(5):2436-2465. PubMed ID: 33592144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying small molecule inhibitors of eukaryotic translation initiation.
    Cencic R; Robert F; Pelletier J
    Methods Enzymol; 2007; 431():269-302. PubMed ID: 17923239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
    Pettersson F; Del Rincon SV; Miller WH
    Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity.
    Santag S; Siegel F; Wengner AM; Lange C; Bömer U; Eis K; Pühler F; Lienau P; Bergemann L; Michels M; von Nussbaum F; Mumberg D; Petersen K
    Cancer Lett; 2017 Apr; 390():21-29. PubMed ID: 28043914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides: the state of the art.
    Aboul-Fadl T
    Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.
    Carvalho A; Chu J; Meinguet C; Kiss R; Vandenbussche G; Masereel B; Wouters J; Kornienko A; Pelletier J; Mathieu V
    Eur J Pharmacol; 2017 Jun; 805():25-35. PubMed ID: 28322844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic translation initiation factors and cancer.
    Ali MU; Ur Rahman MS; Jia Z; Jiang C
    Tumour Biol; 2017 Jun; 39(6):1010428317709805. PubMed ID: 28653885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen.
    Novac O; Guenier AS; Pelletier J
    Nucleic Acids Res; 2004; 32(3):902-15. PubMed ID: 14769948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of intracellular Ca2+ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole.
    Aktas H; Flückiger R; Acosta JA; Savage JM; Palakurthi SS; Halperin JA
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8280-5. PubMed ID: 9653178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation.
    Chen H; Fan YH; Natarajan A; Guo Y; Iyasere J; Harbinski F; Luus L; Christ W; Aktas H; Halperin JA
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5401-5. PubMed ID: 15454234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating Hedgehog in Cancer: Controlling Protein Synthesis.
    D'Amico D; Canettieri G
    Trends Mol Med; 2016 Oct; 22(10):851-862. PubMed ID: 27591077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.
    Yin JY; Dong Z; Liu ZQ; Zhang JT
    Biosci Rep; 2011 Feb; 31(1):1-15. PubMed ID: 20964625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.